EWZ vs XLV
iShares MSCI Brazil ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.59% for EWZ.
- • EWZ pays a higher dividend yield (4.51%).
Side-by-side metrics
| Metric | EWZ | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.59% | 0.08% |
Dividend yield Trailing 12-month yield. | 4.51% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $9.62B | $49.10B |
YTD return | 3.62% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.92 | 0.41 |
P/E ratio | 10.36 | 30.63 |
Last price | $32.42 | $187.94 |
Inception | — | — |
Issuer | iShares | State Street |
EWZ top holdings
| VALE3.SA | Vale SA | 8.65% |
| PETR3.SA | Petroleo Brasileiro SA Petrobras | 8.47% |
| NU | Nu Holdings Ltd Ordinary Shares Class A | 8.47% |
| WEGE3.SA | Weg SA | 3.42% |
| AXIA3.SA | Axia Energia | 2.99% |
| EMBJ3.SA | Embraer SA | 2.99% |
| B3SA3.SA | B3 SA - Brasil Bolsa Balcao | 2.98% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About EWZ
EWZ (iShares MSCI Brazil ETF) is Brazilian large- and mid-cap equities. Managed by iShares, the fund carries $9.6B in assets under management, an expense ratio of 0.59%, a dividend yield of 4.51%. Its largest holding is Vale SA (VALE3.SA), which represents 8.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 1.5%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.